Threat Assessment Brief: Reinfection with SARS-CoV-2: considerations for public health response
Cases with suspected or possible reinfection with SARS-CoV-2 have been recently reported in different countries. In many of these cases, it is uncertain if the individual’s Polymerase Chain Reaction (PCR) test remained positive for a long period of time following the first episode of infection or whether it represents a true reinfection.
The aim of this Threat Assessment Brief is to elucidate the characteristics and frequency of confirmed SARS-CoV-2 reinfection in the literature, to summarise the findings about SARS-CoV-2 infection and antibody development, and to consider the following questions:
• How can a SARS-CoV-2 reinfection be identified?
• How common are SARS-CoV-2 reinfections?
• What is known about the role of reinfection in onward transmission?
• What do these observations mean for acquired immunity?
Finally, options for public health response are proposed.
Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA
Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA
Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination
See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.Read more
Situation updates on COVID-19
Overview of all the data available on the COVID-19 pandemic.Read more